Report an error

Spotted something inaccurate in “First FDA-Approved MASH Drug Resmetirom Targets Liver-Specific Thyroid Receptors”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.